Published in Eur J Clin Microbiol Infect Dis on January 20, 2004
Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study. PLoS Med (2011) 1.68
Mortality and associated risk factors in a cohort of tuberculosis patients treated under DOTS programme in Addis Ababa, Ethiopia. BMC Infect Dis (2011) 1.35
Characterization of Tunisian Mycobacterium tuberculosis rifampin-resistant clinical isolates. J Clin Microbiol (2007) 0.80
Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA (2000) 8.42
How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc Lung Dis (1998) 3.43
Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998. Int J Tuberc Lung Dis (2002) 2.79
Application of new technology to the detection, identification, and antimicrobial susceptibility testing of mycobacteria. Am J Clin Pathol (1994) 1.92
Drug-resistant tuberculosis in Korea, 1994. Int J Tuberc Lung Dis (1997) 1.65
Guidelines for surveillance of drug resistance in tuberculosis. WHO Geneva/IUATLD Paris. International Union Against Tuberculosis and Lung Disease. Int J Tuberc Lung Dis (1998) 1.61
Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia. Int J Tuberc Lung Dis (2002) 1.52
Tuberculosis in Russia. Int J Tuberc Lung Dis (2000) 1.39
Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia. Int J Tuberc Lung Dis (2002) 1.37
Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis. Clin Infect Dis (2002) 1.21
Outcome of multi-drug-resistant tuberculosis in France: a nationwide case-control study. Am J Respir Crit Care Med (1999) 1.15
Problems and solutions for the Stop TB partnership. Lancet Infect Dis (2002) 1.00
Treatment outcome of relapse and defaulter pulmonary tuberculosis patients. Int J Tuberc Lung Dis (2002) 0.98
Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A (1998) 39.20
Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol (1986) 24.31
Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis--one species on the basis of genetic evidence. Appl Environ Microbiol (2000) 7.87
Genetic diversity and temporal variation in the E. coli population of a human host. Genetics (1981) 7.35
Enzyme polymorphism and genetic population structure in Escherichia coli and Shigella. J Gen Microbiol (1983) 7.28
Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories. J Clin Microbiol (1994) 5.84
Population genetics of pathogenic bacteria. Microb Pathog (1987) 5.59
Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc Natl Acad Sci U S A (1986) 5.39
Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern. J Bacteriol (1987) 5.30
Multilocus genotypes determined by enzyme electrophoresis of Neisseria meningitidis isolated from patients with systemic disease and from healthy carriers. J Gen Microbiol (1986) 5.05
Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol (1994) 4.95
Genetic diversity in relation to serotype in Escherichia coli. Infect Immun (1985) 4.11
Antigenic and epidemiologic properties of the ET-37 complex of Neisseria meningitidis. J Infect Dis (1993) 4.02
Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China. Infect Immun (1992) 4.02
Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet (2001) 3.71
Meningococcal disease in The Netherlands, 1958-1990: a steady increase in the incidence since 1982 partially caused by new serotypes and subtypes of Neisseria meningitidis. Clin Infect Dis (1993) 3.63
Genetic relationships and clonal structure of strains of Escherichia coli causing neonatal septicemia and meningitis. Infect Immun (1986) 3.57
Phenotypic and genotypic changes in a new clone complex of Neisseria meningitidis causing disease in The Netherlands, 1958-1990. J Infect Dis (1994) 3.50
Genetic diversity and relationships among strains of Escherichia coli in the intestine and those causing urinary tract infections. Prog Allergy (1983) 3.12
Allelic polymorphism and site-specific recombination in the opc locus of Neisseria meningitidis. Mol Microbiol (1996) 3.00
Fit genotypes and escape variants of subgroup III Neisseria meningitidis during three pandemics of epidemic meningitis. Proc Natl Acad Sci U S A (2001) 2.66
Genotypic Diversity among Bacillus cereus and Bacillus thuringiensis Strains. Appl Environ Microbiol (1994) 2.58
Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine. Infect Immun (1995) 2.44
Genetic structure of population of Bacillus cereus and B. thuringiensis isolates associated with periodontitis and other human infections. J Clin Microbiol (2000) 2.39
Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada. J Clin Microbiol (1991) 2.38
Genetic diversity of Bacillus cereus/B. thuringiensis isolates from natural sources. Curr Microbiol (1998) 2.21
Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease. NIPH Ann (1991) 2.13
Distribution of multilocus genotypes of Escherichia coli within and between host families. J Hyg (Lond) (1984) 2.10
Lymphocyte transformation test in leprosy; correlation of the response with inflammation of lesions. Clin Exp Immunol (1976) 2.08
Genetic relationships and clonal population structure of serotype 2 strains of Neisseria meningitidis. Infect Immun (1987) 2.04
Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med (1998) 1.89
The importance of blood volume cultured on detection of bacteraemia. Acta Pathol Microbiol Scand B (1981) 1.87
Difference in structure between type b and nontypable Haemophilus influenzae populations. Infect Immun (1986) 1.84
Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugs. Eur J Clin Microbiol Infect Dis (2005) 1.80
Ongoing group B Neisseria meningitidis epidemic in São Paulo, Brazil, due to increased prevalence of a single clone of the ET-5 complex. J Clin Microbiol (1992) 1.79
Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in West Africa. Trop Med Int Health (1998) 1.78
Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: a brief survey. NIPH Ann (1991) 1.68
Mycobacterium leprae specific antibodies detected by radioimmunoassay. Scand J Immunol (1978) 1.61
The effect of decentralisation on tuberculosis services in three states of Sudan. Int J Tuberc Lung Dis (2003) 1.59
Injectional anthrax in a heroin skin-popper. Lancet (2000) 1.58
Molecular epidemiology of Mycobacterium tuberculosis in Norway. J Clin Microbiol (2001) 1.54
Genetic diversity of penicillin G-resistant Neisseria meningitidis from Spain. Infect Immun (1989) 1.50
Apparent differences in antimicrobial susceptibility as a consequence of national guidelines. Clin Microbiol Infect (2000) 1.50
Epidemiological analysis of Candida albicans strains by multilocus enzyme electrophoresis. J Clin Microbiol (1993) 1.49
The protective role of antibody responses during Mycobacterium tuberculosis infection. Clin Exp Immunol (2009) 1.48
Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa. J Infect Dis (2009) 1.47
Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial. Infect Immun (1998) 1.46
Characterization of epidemic and nonepidemic Neisseria meningitidis serogroup A strains from Sudan and Sweden. J Clin Microbiol (1990) 1.45
Evaluating an active case-finding strategy to identify smear-positive tuberculosis in rural Ethiopia. Int J Tuberc Lung Dis (2009) 1.44
Molecular basis for distinction of the ET-15 clone within the ET-37 complex of Neisseria meningitidis. J Clin Microbiol (2000) 1.41
Detection of rifampin resistance among isolates of Mycobacterium tuberculosis from Mozambique. Microb Drug Resist (1995) 1.38
Progress in serodiagnosis of Mycobacterium tuberculosis infection. Scand J Immunol (2007) 1.37
Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia. Int J Tuberc Lung Dis (2002) 1.37
The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Guérin (BCG) vaccines: is there a link? Clin Exp Immunol (2006) 1.33
Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). Clin Microbiol Infect (2007) 1.32
Expression of an inaccessible P1.7 subtype epitope on meningococcal class 1 proteins. J Med Microbiol (1993) 1.31
In vitro lymphocyte stimulation in leprosy; simultaneous stimulation with Mycobacterium leprae antigens and phytohaemagglutinin. Clin Exp Immunol (1979) 1.31
Rapid colorimetric method for testing susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin in liquid cultures. J Clin Microbiol (2003) 1.31
Application of multilocus enzyme gel electrophoresis to Haemophilus influenzae. Infect Immun (1986) 1.30
Treatment results of DOTS in 1797 Sudanese tuberculosis patients with or without HIV co-infection. Int J Tuberc Lung Dis (2002) 1.30
Prevalence of pulmonary tuberculosis and associated risk factors in Eastern Ethiopian prisons. Int J Tuberc Lung Dis (2011) 1.27
A new variant of serosubtype P1.16 in Neisseria meningitidis from Norway, associated with increased resistance to bactericidal antibodies induced by a serogroup B outer membrane protein vaccine. Microb Pathog (1993) 1.25
Contamination pattern of Listeria monocytogenes and other Listeria spp. in a salmon slaughterhouse and smoked salmon processing plant. Int J Food Microbiol (1995) 1.24
Mycobacterial antigens in antibody responses of leprosy patients. Int J Lepr Other Mycobact Dis (1976) 1.23
Psychosocial determinants of sexual activity and condom use intention among youth in Addis Ababa, Ethiopia. Int J STD AIDS (2002) 1.21
Epidemics of serogroup A Neisseria meningitidis of subgroup III in Africa, 1989-94. Epidemiol Infect (1996) 1.20
Resident colonic Escherichia coli strains frequently display uropathogenic characteristics. J Infect Dis (1992) 1.19
Antigenic heterogeneity in patients with reactions in borderline leprosy. Br Med J (1975) 1.18
Anthrax among heroin users in Europe possibly caused by same Bacillus anthracis strain since 2000. Euro Surveill (2013) 1.18
Characteristics of serogroup A Neisseria meningitidis responsible for an epidemic in Ethiopia, 1988-89. Scand J Infect Dis (1990) 1.18
Relation of grading of sputum smears with clinical features of tuberculosis patients in routine practice in Sudan. Int J Tuberc Lung Dis (2002) 1.17
A mouse model for slowly progressive primary tuberculosis. Scand J Immunol (1999) 1.16
Improved medium for the transportation of gonococcal specimens. Acta Pathol Microbiol Immunol Scand B (1982) 1.16
Plasma factors in delayed-type hypersensitivity. Augmentation of lymphocyte responses in borderline leprosy reactions. Clin Exp Immunol (1976) 1.15
Genetic variation among Staphylococcus aureus strains from Norwegian bulk milk. Appl Environ Microbiol (2005) 1.14
Randomly amplified polymorphic DNA genotyping of serogroup A meningococci yields results similar to those obtained by multilocus enzyme electrophoresis and reveals new genotypes. J Clin Microbiol (1998) 1.14
Structure and function of repetitive sequence elements associated with a highly polymorphic domain of the Neisseria meningitidis PilQ protein. Mol Microbiol (1998) 1.13
Identification of nasopharyngeal carriage of an outbreak strain of Neisseria meningitidis by pulsed-field gel electrophoresis versus phenotypic methods. J Med Microbiol (1998) 1.13
Molecular polymorphism and epidemiology of Neisseria meningitidis immunoglobulin A1 proteases. Proc Natl Acad Sci U S A (1992) 1.13
Comparison among opsonic activity, antimeningococcal immunoglobulin G response, and serum bactericidal activity against meningococci in sera from vaccinees after immunization with a serogroup B outer membrane vesicle vaccine. Infect Immun (1995) 1.10
Emergence of a new virulent clone within the electrophoretic type 5 complex of serogroup B meningococci in Norway. Clin Diagn Lab Immunol (1995) 1.10
Comparison of epidemiological marker methods for identification of Salmonella typhimurium isolates from an outbreak caused by contaminated chocolate. J Clin Microbiol (1989) 1.08
Antibodies against BCG antigen 60 in mycobacterial infection. Br Med J (1977) 1.08
Characterization of Neisseria meningitidis serogroup A strains from an outbreak in France by serotype, serosubtype, multilocus enzyme genotype and outer membrane protein pattern. Eur J Clin Microbiol Infect Dis (1991) 1.07
Differences in genetic diversity of nonecapsulated Haemophilus influenzae from various diseases. Microbiology (1997) 1.06
Heterogeneity of tbpB, the transferrin-binding protein B gene, among serogroup B Neisseria meningitidis strains of the ET-5 complex. Clin Diagn Lab Immunol (1997) 1.06
Genetic characterization of a new variant within the ET-37 complex of Neisseria meningitidis associated with outbreaks in various parts of the world. Epidemiol Infect (2000) 1.06
Macrolide-resistant Streptococcus pyogenes in Norway: population structure and resistance determinants. Antimicrob Agents Chemother (2006) 1.04